A5394: Oral TLR8 Agonist Selgantolimod on HBsAg

Temporarily Closed to Screening

Safety, Tolerability, and Impact of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants with Both Chronic Hepatitis B and HIV

Treatment Category

Hepatitis

Sites